PBK and Miyoshi myopathy: In conclusion, PBK is shown to be a novel therapeutic target in MM, and the discovery of possible active sites by FHND004 provides a new approach for MM targeted therapy [32], which may be an alternative choice for the usage of PBK inhibitors.